GGrantIndex
Sort

17,828 grants matching crispr

Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link

$606,154
Cornelia M Ulrich · University Of Utah · R01 · FY2024 · CA

Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic risk

$606,127
Ginger E Nicol · Washington University · R01 · FY2025 · MH

Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer

$606,038
Sidharth Venkata Puram · Washington University · R01 · FY2025 · DE

Immunoengineering of donor lungs to optimize long-term graft function

$605,871
Shaf Keshavjee · University Health Network · R01 · FY2024 · AI

Integrating epigenomics with DNA breathing dynamics for human non-coding disease variants

$605,699
Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2021 · MH

Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models

$605,693
Lilia M Iakoucheva · University Of California, San Diego · R01 · FY2023 · ES

Genomic profiling mediating the protective effect of social reward on opioid craving

$605,672
Marco Venniro · University Of Maryland Baltimore · R01 · FY2025 · DA

Ferroptosis in knock-in sepiapterin reductase mutation rabbits

$605,476
Sidhartha Tan · Wayne State University · R01 · FY2023 · NS

The role of SERPINB3 in cervical cancer therapeutic resistance

$605,457
Stephanie Subasic Markovina · Washington University · R01 · FY2024 · CA

Enhancing the C. elegans animal resource through genome editing

$605,202
Ann E. Rougvie · University Of Minnesota · R24 · FY2022 · OD

Enhancing the C. elegans animal resource through genome editing

$605,202
Ann E. Rougvie · University Of Minnesota · R24 · FY2024 · OD

Enhancing the C. elegans animal resource through genome editing

$605,202
Ann E. Rougvie · University Of Minnesota · R24 · FY2023 · OD

Enhancing the C. elegans animal resource through genome editing

$605,202
Ann E. Rougvie · University Of Minnesota · R24 · FY2021 · OD

Mechanisms of DUX4 mediated FSHD pathology

$605,201
Peter L Jones · University Of Nevada Reno · R01 · FY2023 · AR

Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1

$605,184
Aristotelis Tsirigos · New York University School Of Medicine · R01 · FY2023 · CA

Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1

$605,181
Aristotelis Tsirigos · New York University School Of Medicine · R01 · FY2022 · CA

Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer

$605,070
John D Minna · Ut Southwestern Medical Center · U01 · FY2017 · CA

Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer

$605,070
John D Minna · Ut Southwestern Medical Center · U01 · FY2021 · CA

Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer

$605,070
John D Minna · Ut Southwestern Medical Center · U01 · FY2018 · CA

Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer

$605,070
John D Minna · Ut Southwestern Medical Center · U01 · FY2020 · CA

MKP5 allostery in MAPK regulation and signaling in the heart

$604,781
Anton M Bennett · Yale University · R01 · FY2023 · HL

Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models

$604,748
Lilia M Iakoucheva · University Of California, San Diego · R01 · FY2025 · ES

Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect

$604,596
Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL

Study cell cycle regulation in dormant tumor cells

$604,582
Steven Cappell · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Mitochondrial Metabolism and Cancer

$604,507
Navdeep S. Chandel · Northwestern University At Chicago · R01 · FY2025 · CA